An “off the shelf” vascular allograft supports angiogenic growth in three-dimensional tissue engineering  Johann M. Zdolsek, MD, Wayne A. Morrison, MB.

Slides:



Advertisements
Similar presentations
Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses  Chao-Hung Wang, MD, Kuo-Ti Chen, MS, Hsiu-Fu Mei,
Advertisements

Shunya Shindo, M. D. , Atsuhiko Takagi, M. D. , Anthony D
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
The use of pimonidazole to characterise hypoxia in the internal environment of an in vivo tissue engineering chamber  S.O.P. Hofer, G.M. Mitchell, A.J.
Peter W. Henderson, MD, George K
Diet-induced obesity drives negative mouse vein graft wall remodeling
Vein wall re-endothelialization after deep vein thrombosis is improved with low- molecular-weight heparin  Daria K. Moaveni, MD, Erin M. Lynch, MS, Cathy.
Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture  Bryan W. Tillman, MD, PhD,
Decellularized vein as a potential scaffold for vascular tissue engineering  Patrick J Schaner, MD, Niels D Martin, MD, Thomas N Tulenko, PhD, Irving M.
Yi-kuan Chen, MD, Xue-mei Jiang, MSc, Jian-ping Gong, MD 
Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production 
Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,
Lysyl oxidase expression in a rat model of arterial balloon injury
Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: An autopsy study  Søren Dalager, MD,
Central venous catheter failure is induced by injury and can be prevented by stabilizing the catheter tip  Ted R. Kohler, MD, Thomas R. Kirkman, BS  Journal.
Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model  Jennifer L. Herington, Ph.D., Dana.
Vascular anastomoses with laser energy
Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts  Damiano Mugnai, MD, Jean-Christophe Tille, MD,
Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting 
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Lucas P. Neff, MD, Bryan W. Tillman, MD, PhD, Saami K
Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons  Peter A. Schneider, MD, Stephen R.
Basic fibroblast growth factor slow release stent graft for endovascular aortic aneurysm repair: A canine model experiment  Masaki Kajimoto, MD, Takatsugu.
Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material  Soichiro Enomoto, MD, PhD, Makoto Sumi, MD,
D. Z. Xiang, MD, E. K. Verbeken, MD, PhD, A. T. L. Van Lommel, PhD, M
Decellularized vein as a potential scaffold for vascular tissue engineering  Patrick J Schaner, MD, Niels D Martin, MD, Thomas N Tulenko, PhD, Irving M.
Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model 
Influence of endothelial cell seeding on platelet deposition and patency in small- diameter Dacron arterial grafts  Brent T. Allen, M.D., Julie A. Long,
Tissue-engineered blood vessel substitute by reconstruction of endothelium using mesenchymal stem cells induced by platelet growth factors  Matheus Bertanha,
Utilization of shape memory in external vein-graft meshes allows extreme diameter constriction for suppressing intimal hyperplasia: A non-human primate.
Diet-induced obesity drives negative mouse vein graft wall remodeling
Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath  Vikram Vijayan,
Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts  Manfred Deutsch, MD, Johann Meinhart, PhD, Peter Zilla,
Endovascular aneurysmal models at the external iliac artery of dogs
Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia  Insu Baek, MS, Cheng Zhe Bai, PhD,
J. A. C. Buckels, M. D. , F. R. C. S. , A. G. Nordestgaard, M. D. , S
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells  Toshiharu Shin’oka, MD, PhD, Goki Matsumura,
Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft  Akio Kodama, MD, Kimihiro Komori, MD, PhD, Keisuke Hattori, MD,
Conformational stress and anastomotic hyperplasia
Remodeling in peripheral vein graft revisions: Serial study with three-dimensional ultrasound imaging  Daniel F. Leotta, PhD, Jean F. Primozich, BS, Kirk.
Differentiating transmural from transanastomotic prosthetic graft endothelialization through an isolation loop-graft model  Timothy Pennel, MBChB, Peter.
The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis  Joe F. Baldwin,
Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical.
Morphologic change in rabbit femoral arteries induced by storage at four degrees Celsius and by subsequent reperfusion  Daniel Crowe, BSc(Hons), Kevin.
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts  Helen M.
The effects of stenting and endothelial denudation on aneurysm and branch occlusion in experimental aneurysm models  Tim Darsaut, MD, Fatiha Bouzeghrane,
Vein graft failure Journal of Vascular Surgery
Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models  Alan B. Lumsden,
Hiromichi Miwa, MD, Takehisa Matsuda, PhD  Journal of Vascular Surgery 
The fate of an endothelium layer after preconditioning
Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses  Chao-Hung Wang, MD, Kuo-Ti Chen, MS, Hsiu-Fu Mei,
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene.
Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity  Jeffrey M. Rhodes, MD, Jae-Sung Cho, MD, Peter.
Lisheng Zhang, MD, Leigh Brian, MS, Neil J. Freedman, MD 
Impact of endothelial cell seeding on long-term patency and subendothelial proliferation in a small-caliber highly porous polytetrafluoroethylene graft 
Robert A. McCready, M. D. , Margaret A. Price, B. S. , Richard J
Robert Guidoin, Ph. D. , Henri-Paul Noël, M. D. , Serge Dubé, M. D
Neointimal hyperplasia on a cell-seeded polytetrafluoroethylene graft is promoted by transfer of tissue plasminogen activator gene and inhibited by transfer.
Volume 59, Issue 6, Pages (June 2001)
Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: A pilot study  Wangde Dai,
Free radical attenuation prevents thrombosis and enables photochemical inhibition of vein graft intimal hyperplasia  Giuseppe R Nigri, MD, PhD, Sylvie.
Diabetes mellitus and experimental vein graft structure and function
Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts  Wai-Leng Chue, MBBS, Gordon R Campbell, PhD, Noel Caplice, MBBS,
Human saphenous vein allograft bypass grafts: Immune response
Richard L. Binns, MD  Journal of Vascular Surgery 
Joseph J. Piotrowski, MD, Glenn C. Hunter, MD, Cleamond D
The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene.
The effects of stenting and endothelial denudation on aneurysm and branch occlusion in experimental aneurysm models  Tim Darsaut, MD, Fatiha Bouzeghrane,
Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: An immunohistochemical.
Presentation transcript:

An “off the shelf” vascular allograft supports angiogenic growth in three-dimensional tissue engineering  Johann M. Zdolsek, MD, Wayne A. Morrison, MB BS, MD, Aaron M. Dingle, B Sc (Hons), Jason A. Palmer, B Sc (Hons), Anthony J. Penington, MB BS, Geraldine Margaret Mitchell, PhD  Journal of Vascular Surgery  Volume 53, Issue 2, Pages 435-444 (February 2011) DOI: 10.1016/j.jvs.2010.08.019 Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 1 a, Tissue engineering chambers, volume 1.7 mL. Left: chamber with perforations, right: smooth chamber without perforations. b, Arteriovenous loops (AVLs) construct with autologous vein graft inserted (arrow) placed on a perforated chamber base. c, AVL construct with cold-stored vein-graft (arrow) inserted, sitting on a smooth unperforated chamber base. d, e, f, and g, Macroscopic appearance of constructs (arrows) at 6 weeks. Note smaller amount of vascularized (red) tissue and larger amount of fibrin (yellow material), not yet vascularized in (d and f) (smooth chambers). In (e and g), note the well-vascularized tissue with knobs of new tissue originating from tissue growth from outside the chamber coming through the chamber perforations into the fibrin surrounding the AVL. h, Weight, and (i), volume of constructs at harvest at 2 or 6 weeks (mean values ± SEM). *Weight of perforated chamber constructs significantly greater than smooth chamber constructs (P = .015). #Volume of perforated chamber constructs significantly greater than smooth chamber constructs (P = .006). Journal of Vascular Surgery 2011 53, 435-444DOI: (10.1016/j.jvs.2010.08.019) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 2 Autologous vein graft constructs. a, Autologous vein in arteriovenous loops (AVLs) in a smooth chamber at 2 weeks. Note that new blood vessel/connective tissue (CT) growth into the fibrin (F) from the AVL (A) is not complete. Asterisk indicates hemorrhage into the fibrin. b, Autologous vein in AVL (A) at 6 weeks. The vascularized CT growth has completely replaced the fibrin. c, The autograft vein wall at 2 weeks, lined with endothelium (arrow). No branches occurred from the graft, and new blood vessels and CT surround the autologous graft. d, Autologous vein graft in the AVL (A) in a perforated chamber at 2 weeks. Note the “knobs” (arrows) of new tissue that originate from the perforations in the chamber. e, Autologous vein graft in the AVL (A) in a perforated chamber at 6 weeks. Arrows indicate the ‘knobs’ of tissue originating from chamber perforations. f, The autologous vein wall (asterisk) surrounded by intensely angiogenic tissue (note numerous lectin labeled blood vessels outside the autograft vein, arrows indicate two of these new blood vessels). g, Autograft vein AVL construct in a perforated chamber at 2 weeks. Note that knob-like (arrows) ingrowths of vascularized tissue (VT) from outside the chamber via the perforations into fibrin (F) surrounding the AVL. At this stage, the “knobs” of tissue are yet to unite with the vascularized connective tissue growing around the AVL (not shown). h, Lectin labeled low power figure of an autograft vein AVL construct in a perforated chamber at 6 weeks demonstrating a tract of blood vessels (arrow) extending from the knob of tissue formed via the perforation into the vascularized tissue around the AVL (A). i, The femoral vein portion of an occluded AVL demonstrating dilated branches (arrow) bringing blood from the new microcirculatory bed into the femoral vein. a-e, g, and i, Hematoxylin and eosin stained 5μm thick paraffin sections. f and h, Lectin labeling of 5μm thick paraffin sections. Scale bars in: a, b, d, e, and g, = 1000 μm. Scale bars in: c and f = 200 μm, scale bar in h = 500 μm. Journal of Vascular Surgery 2011 53, 435-444DOI: (10.1016/j.jvs.2010.08.019) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 3 Cold-stored allograft vein constructs. a, Cold-stored allograft vein in arteriovenous loops (AVLs) construct in a smooth chamber at 2 weeks. The AVL (A) is surrounded by some vascularized connective tissue (CT), but hemorrhage and fibrin still exist in the chamber (asterisk). b, Cold-stored allograft vein in an AVL (A) construct in a smooth chamber at 6 weeks. The AVL is surrounded by vascularized CT and the fibrin and hemorrhage have disappeared. c, A cold-stored allograft vein wall at 2 weeks, it is acellular (asterisk) and does not have an endothelial lining (arrow) and is surrounded by fibrin (F). d, A cold-stored allograft vein at 2 weeks in a perforated chamber. The AVL (A) is still largely surrounded by fibrin/hemorrhage (asterisks) and new vascularized CT growth is minimal. Arrow indicates “knob” of tissue entering construct via chamber perforations. e, A cold-stored allograft vein in an AVL (A) at 6 weeks in a perforated chamber. The amount of vascularized CT has greatly increased compared to 2 weeks and little fibrin can be seen. Arrow indicates “knob” of tissue entering construct via chamber perforations. f, A cold-stored allograft vein in an AVL construct at 6 weeks. An endothelial lining is evident (arrow), the graft wall is still largely acellular (asterisk), and the graft is surrounded by new vascularized CT. g, Lectin labeled cold-stored allograft vein wall at 6 weeks (asterisk) surrounded by numerous lectin-positive new capillaries (two capillaries indicated by arrows). h, Lectin labeled allograft wall at 6 weeks at an anastomosis indicating a lack of endothelial lining (lectin-negative, arrow) and neointima formation (N). a, b, c, d, e, and f, Hematoxylin and eosin stained 5 μm thick paraffin sections. g and h, Lectin labeled 5 μm thick paraffin sections. Scale bars a, b, and e = 1000 μm, c and d, the scale bars = 500 μm, f and g, the scale bars = 200 μm, and in (h) the scale bar = 50 μm. Journal of Vascular Surgery 2011 53, 435-444DOI: (10.1016/j.jvs.2010.08.019) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 4 a-f, phosphotungstic acid-hematoxylin (PTAH) labeling of constructs. a, Autologous vein construct at 2 weeks. The arrows indicate peripheral fibrin. b, High power view of fibrin areas from (a). c, Autologous vein construct at 6 weeks, the peripheral fibrin (arrow) is reduced. d, Cold-stored vein construct at 2 weeks. The arrow indicates fibrin. e, High power view of fibrin areas from (d). f, Cold-stored vein construct at 6 weeks, demonstrating less fibrin (arrow) than at 2 weeks. g-h, Masson's trichrome staining of constructs. g, Autologous vein construct at 2 weeks. Blue areas (arrow) indicate new collagen around the arteriovenous loop (AVL). h, High power view of the autologous vein wall with a neointimal covering (arrow). The surrounding new tissue includes many capillaries in a collagenous connective tissue (blue areas). i, Cold stored vein allograft construct at 2 weeks. Blue areas (arrow) indicate new collagen around the AVL (similar to g). j, High power view of the cold stored vein wall (arrow) surrounded by new vascularized connective tissue including much collagen (blue areas). k-m, Giemsa staining of the graft wall. k, Autologous vein wall (bracket) at 2 weeks. Note cells in wall and endothelium (arrow) on luminal surface. l, Cold-stored vein wall at 2 weeks. Note a small accumulation of lymphocytes outside the vein wall (arrow) - this was not common. There are few cells in the graft wall (bracket) and the internal elastic lamina covers the luminal surface. m, Cold-stored vein wall at 2 weeks. Similar to l, but there are no lymphocytes in or near the graft wall. n, High power view of graft wall (bracket; PTAH staining). Note the lack of cells in the graft wall and the broken shreds of internal elastic lamina (arrow) on the graft luminal surface - note there is no endothelium. Scale bars: a, c, d, f, g, and i, scale bar = 2000 μm. b, e, h, and j, scale bars = 200 μm. k, l, m, and n, scale bar = 50 μm. Journal of Vascular Surgery 2011 53, 435-444DOI: (10.1016/j.jvs.2010.08.019) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 5 a, The percent volume of arteriovenous loop (AVL) construct tissue components AVL, fibrin, new connective tissue, and blood in four groups at 6 weeks: A, autograft vein; CS, cold-stored allograft vein; P, perforated chambers; S, smooth chambers. There was no difference in the tissue composition in constructs with autograft veins or cold-stored allograft veins. However, in relation to chamber type, there was a significant increase in new connective tissue in perforated chambers (regardless of graft type) compared to smooth chambers (*P = .001). b, The percent vascular volume of new blood vessels in four groups at 6 weeks. There was no difference in percent vascular volume related to graft or chamber type. c, The absolute vascular volume of AVL construct components in four groups at 6 weeks. The only significant difference was a significant increase in new connective tissue absolute volume in perforated chambers (#) regardless of whether autograft or cold-stored allograft veins were used (#P = .01). d, The absolute vascular volume of all four groups at 6 weeks. Although it seems that vascular volume was increased in perforated chambers, this was not significant. There was no difference in vascular volume generated related to graft type. Journal of Vascular Surgery 2011 53, 435-444DOI: (10.1016/j.jvs.2010.08.019) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 6 a, Comparison of the new percent vascular volume generated in patent and occluded autologous vein constructs and cold-stored vein constructs. There was no significant difference in the percent vascular volume generated based on patency status. b, Comparison of the percent connective tissue volume generated in patent and occluded autologous vein constructs and cold-stored vein constructs. There was no significant difference in the percent connective tissue generated based on patency status. c, Comparison of the percent fibrin volume generated in patent and occluded autologous vein constructs and cold-stored vein constructs. There was no significant difference in the percent fibrin volume based on patency status. AVLs, Arteriovenous loops. Journal of Vascular Surgery 2011 53, 435-444DOI: (10.1016/j.jvs.2010.08.019) Copyright © 2011 Society for Vascular Surgery Terms and Conditions